James D. Finklea

The University of Texas Southwestern Medical Center

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Development of metabolic syndrome in people with Cystic Fibrosis one year after exposure to elexacaftor-tezacaftor-ivacaftor”.

Development of metabolic syndrome in people with Cystic Fibrosis one year after exposure to elexacaftor-tezacaftor-ivacaftor

Journal of Cystic Fibrosis(2024)10.1016/j.jcf.2024.09.022

N/A

0DataRank · unranked

27 citations

Hannah Smith, Sasan Mirfakhraee, Joan Reisch, Leah A. Cohen, Raksha Jain +2 more

Impact of glucagon-like-peptide-1 receptor agonist therapy on pulmonary function in people with cystic fibrosis who achieve normal body mass index

Journal of Cystic Fibrosis(2025)10.1016/j.jcf.2025.10.006

N/A

0DataRank · unranked

3 citations

Katie Kaput, Amber Neece, Jessica Abramowitz, Marconi Abreu, G. Ratti +4 more